BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
156 hedge funds and large institutions have $134M invested in bluebird bio in 2024 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 61 increasing their positions, 40 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
156
Holders Change
-30
Holders Change %
-16.13%
% of All Funds
2.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
61
Reduced
40
Closed
54
Calls
$1.48M
Puts
$2.49M
Net Calls
-$1.01M
Net Calls Change
-$1.18M
Top Buyers
1 |
BlackRock
New York
|
$19.4M |
2 |
Ameriprise
Minneapolis,
Minnesota
|
$8.18M |
3 |
Millennium Management
New York
|
$7.99M |
4 |
Geode Capital Management
Boston,
Massachusetts
|
$5.53M |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
$13.4M |